Showing results (1891-1900 of 5,146) with videos related to
Sort By:
Pageof 515
Multiple Sclerosis and Related Disorders|March 15, 2022
Development and evaluation of evidence-based patient information handbooks about multiple sclerosis immunotherapiesA Schneider, E Fasshauer, J Scheiderbauer, et al.Multiple Sclerosis and Related Disorders|March 5, 2022
A point-of-care diagnostic test for aquaporin-4 antibody seropositive neuromyelitis opticaDylan R Rice, Shuhei Nishiyama, Santiago Pardo, et al.Multiple Sclerosis and Related Disorders|February 26, 2022
Percutaneous posterior tibial nerve stimulation (PTNS) for lower urinary tract symptoms (LUTSs) treatment in patients with multiple sclerosis (MS): A systematic review and meta-analysisFatemeh Guitynavard, Omid Mirmosayyeb, Emami Razavi Vs Razavi, et al.Multiple Sclerosis and Related Disorders|February 26, 2022
Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive testsDaniel Merlo, Tomas Kalincik, Chao Zhu, et al.Multiple Sclerosis and Related Disorders|February 26, 2022
The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysisMaria-Ioanna Stefanou, Lina Palaiodimou, Aristeidis H Katsanos, et al.Multiple Sclerosis and Related Disorders|February 26, 2022
Quantification of normal-appearing white matter damage in early relapse-onset multiple sclerosis through neurite orientation dispersion and density imagingMonica Margoni, Umberto Villani, Erica Silvestri, et al.Multiple Sclerosis and Related Disorders|February 26, 2022
Validation of the fatigue severity scale in Croatian population of patients with multiple sclerosis disease: Factor structure, internal consistency, and correlatesAna Jerković, Ana Proroković, Meri Matijaca, et al.Multiple Sclerosis and Related Disorders|February 26, 2022
Feasibility and efficacy of home-based neurofunctional exercise vs. resistance exercise programs for ambulatory disability of multiple sclerosis patients with cognitive impairmentMajid Mardaniyan Ghahfarrokhi, Ebrahim Banitalebi, Mohammad Faramarzi, et al.Multiple Sclerosis and Related Disorders|February 26, 2022
Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint studyG Saposnik, S Andhavarapu, Ó Fernández, et al.Multiple Sclerosis and Related Disorders|February 26, 2022
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in ItalyRiccardo Giossi, Alessandra Consonni, Valentina Torri Clerici, et al.Pageof 515